Diabetic nephropathy

M. E. Molitch; R. A. DeFronzo; M. J. Franz; W. F. Keane; C. E. Mogensen; H. H. Parving; M. W. Steffes

Diabetic nephropathy

M. E. Molitch, R. A. DeFronzo, M. J. Franz, W. F. Keane, C. E. Mogensen, H. H. Parving, M. W. Steffes

Research output: Contribution to journal › Short survey › peer-review

Abstract

Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

Original language	English (US)
Pages (from-to)	S66-S69
Journal	Diabetes care
Volume	22
Issue number	1 SUPPL.
State	Published - Jan 1 1999
Externally published	Yes

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialized Nursing

Cite this

@article{94d05a99532c42d7b346aed63424f528,

title = "Diabetic nephropathy",

abstract = "Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.",

author = "Molitch, {M. E.} and DeFronzo, {R. A.} and Franz, {M. J.} and Keane, {W. F.} and Mogensen, {C. E.} and Parving, {H. H.} and Steffes, {M. W.}",

year = "1999",

month = jan,

day = "1",

language = "English (US)",

volume = "22",

pages = "S66--S69",

journal = "Diabetes Care",

issn = "1935-5548",

publisher = "American Diabetes Association Inc.",

number = "1 SUPPL.",

}

TY - JOUR

T1 - Diabetic nephropathy

AU - Molitch, M. E.

AU - DeFronzo, R. A.

AU - Franz, M. J.

AU - Keane, W. F.

AU - Mogensen, C. E.

AU - Parving, H. H.

AU - Steffes, M. W.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

AB - Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

UR - http://www.scopus.com/inward/record.url?scp=0032947072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032947072&partnerID=8YFLogxK

M3 - Short survey

AN - SCOPUS:0032947072

SN - 1935-5548

VL - 22

SP - S66-S69

JO - Diabetes Care

JF - Diabetes Care

IS - 1 SUPPL.

ER -

Diabetic nephropathy

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this